Inflammation and net-like protein structures in cerebral cavernous malformations
2022-03-28
In the condition known as cavernoma, lesions arise in a cluster of blood vessels in the brain, spinal cord or retina. Researchers at IGP now show in a new study that white blood cells and protein structures associated with the immune response infiltrate the vessel lesions. The findings support that inflammation has a role in the development of cavernoma and indicate a potential biomarker for the disease.
The vascular lesions, or blood-vessel malformations, that appear in a cerebral cavernoma – also known as a cerebral cavernous malformation (CCM) resemble mulberries. They bleed easily, which may cause epileptic attack, neurological problems and stroke. The condition is due to genetic mutations that may be inherited or occur spontaneously, and is incurable at present.
Research in recent years has suggested that inflammation is involved in CCM. I the new study, the researchers have examined in detail which immune cells respond in CCM. They could also show for the first time that net-like protein structures called NETs are formed in CCM. NETs (for Neutrophil Extracellular Traps) are made up of cell nuclei and cell structures and are associated with the immune response.
“We have used genetically modified mice where a mutated form of a certain gene results in CCM. We found that neutrophils, a type white blood cell, are the first to be recruited to the vessel lesions in mice with CCM. In addition, we detected NETs both in the brain and circulating in the blood. In mice without CCM we didn’t find any NETs,” says Peetra Magnusson, who has led the study.
NETs normally act as a defense in the body by capturing and destroying intruders such as bacteria. High levels of NETs have previously been shown in cancer patients and they are an important component in COVID. These net-like structures can cause vessel damage and the formation of blood clots. Their role in CCM has not been clarified but when the researchers tested a treatment that degraded the NETs, the CCM-related vessel damages were reduced.
NET-like protein structures (cyan). The immune cell
was isolated from a mouse with CCM.
Image captured by Maria A. Globisch with support
from the BioVis platform.
The researchers could also detect NETs in brain tissues from patients with CCM, both the inherited form and the one that occurs spontaneously.
“The presence of NETs in CCM patients indicate that they have a role in the disease also in humans. We hope that future studies will increase the knowledge about the importance of immune cells in disease development and whether NETs can be used as a biomarker for CCM,” says Peetra Magnusson.
The study is a collaboration with researchers in Italy, Finland and the UK. It has been published in the journal Cellular and Molecular Life Sciences.
More information:
Paper in Cellular and Molecular Life Sciences
Peetra Magnusson’s research in Elisabetta Dejana’s group
-
Oral contraceptives and hormone treatment increase stroke risk
2022-06-27
A new study from IGP show that oral contraceptives and also hormone replacement therapy at menopause increase the risk of stroke. The increased risk was largest during the first year of treatment, after which it declined. The study, which is now published in the journal Stroke, is based on data from more than a quarter of a million women from the database UK Biobank.
-
Rare genetic variants are not the main cause of common diseases
2022-05-13
Although some rare variants can significantly increase the risk of disease for a few individuals, the majority of the genetic contribution to common diseases is due to a combination of many common genetic variants with small effects. This is shown by researchers at IGP and other departments at Uppsala University in a new comprehensive study published in the journal Nature Communications.
-
Subgroups of brain tumours associated with cell origin and disease prognosis
2022-04-25
Researchers at IGP have detected different subgroups of the brain tumour form glioblastoma, where the cancer cells’ properties depend on which cell type they originate from. The used analysis method could also separate glioblastoma patients with significant differences in survival. The findings open up for identifying specific therapeutic targets for the new subgroups of glioblastoma.
-
Armed CAR-T cells to better fight cancer
2022-04-04
Immunotherapy is increasingly becoming a successful way to treat cancer. Researchers at IGP have now developed armed CAR-T cells that reinforce the immune defence against cancer and that could increase the possibilities to successfully treat solid tumours. The study has been published in the journal Nature BioMedical Engineering.
-
Inflammation and net-like protein structures in cerebral cavernous malformations
2022-03-28
In the condition known as cavernoma, lesions arise in a cluster of blood vessels in the brain, spinal cord or retina. Researchers at IGP now show in a new study that white blood cells and protein structures associated with the immune response infiltrate the vessel lesions. The findings support that inflammation has a role in the development of cavernoma and indicate a potential biomarker for the disease.
-
Protein landscape on cancer cells mapped with new technology
2022-03-03
In recent years, great advances have been made in the development of new, successful immunotherapies to treat cancer. Two types of targeted immunotherapies that have revolutionised areas of cancer care are CAR T-cell therapy and antibody treatments. However, there are still significant challenges in the identification of cancer cell surface proteins that function as targets for immunotherapies. Mattias Belting, professor at Lund University and senior consultant at Skåne University Hospital, and guest professor at IGP, is well on the way and his group’s findings are now published in the journal PNAS.
-
CRISPR-Cas9 can generate unexpected, heritable mutations
2022-02-03
CRISPR-Cas9, the “genetic scissors”, creates new potential for curing diseases; but treatments must be reliable. In a new study, researchers have discovered that the method can give rise to unforeseen changes in DNA that can be inherited by the next generation. These scientists therefore urge caution and meticulous validation before using CRISPR-Cas9 for medical purposes.
-
New technology to study DNA in archived tissue samples
2022-01-19
Researchers at IGP have developed a technology that allows studies of DNA profiles in archived tissue samples. The technology permits investigators to better understand regulation of gene activity in cancer and precision medicine.
-
New genes associated with relapse of acute myeloid leukemia
2022-01-13
In the blood cancer type acute myeloid leukemia, it is common that patients relapse some time after treatment. Researchers from IGP have in a new study identified genes that seem to be associated with the risk of relapse. The findings may form the basis for new treatment strategies and contribute to better survival for patients with acute myeloid leukemia.